4.7 Letter

It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

Journal

BIOLOGICAL PSYCHIATRY
Volume 82, Issue 7, Pages E51-E59

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2017.03.007

Keywords

-

Funding

  1. VA Office of Research and Development Clinical Science Research & Development Service and Cooperative Studies Program
  2. National Institutes of Health
  3. Pfizer
  4. AstraZeneca
  5. National Institute on Alcohol Abuse and Alcoholism
  6. Tonix
  7. Merck
  8. Allergan
  9. Otsuka
  10. National Institute of Mental Health
  11. Department of Veterans Affairs
  12. Department of Defense
  13. Lilly Pharmaceuticals
  14. VA Health Services Research and Development Career Development Award

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available